Order book surge fails to mask margin collapse; execution risk ahead

Revenue declined 3.3% YoY to ₹210.4 Cr

Order book ₹1,244 Cr up 19% QoQ; revenue down 3.3% YoY

Margin collapsed from 15.4% QoQ (77% decline); CoD 76.2% vs 70% QoQ

No tangible productivity benefits quantified yet; management holding for future

Some logos lost, 3 new logos added; vague on numbers

Order book ₹1,244 Cr vs ₹1,044 Cr (Mar 26)—+19% QoQ. 88% from products (₹1,096 Cr); 12% from services/AMCs. Largest jump in recent quarters.

Q1 FY27 ₹210.4 Cr down 3.3% YoY (vs prior call expectation of order book driving growth). Timing gap: order book growing, revenue shrinking.

EBITDA margin collapsed to 3.6% from 15.4% prior quarter. Cost structure ballooned: CoD 76.2%, S&M 10%, G&A 10.1% vs 70%, 7.1%, 7.5% respectively.

Lost one major NBFC (top-5 customer) to competitor. Added 3 new logos. Net impact negative; top-5 concentration still 28.1% of revenue.

Management acknowledged slipping from 25-27% historical margins into 'deeply discounted' structure again due to competitive pressure and low order book in prior 2 years.

Theoretically yes, but practically unlikely. Confidence in product positioning and market traction; this is one-off case.

Last quarter ₹600 Cr order book, this quarter ₹300+ Cr. Order book is reflection of S&M team effort; revenue impact delayed by implementation cycles.

Marketing expenses up (investing in global markets). Diesel/power costs up due to war situation. RSU grants also impacted.

More or less in line with existing track record. AMC contracts are long-term (5 years), not comparable to shorter implementation projects.

Some logos left, added 3 new. One-time capitalization event with biggest customer impacted last quarter.

Implementation cycles vary customer-to-customer; not quarterly phenomenon. Depends on legacy migration complexity and volume.

Lower order book in past 2 years forced price cuts. Now that orders are back, we'll see recovery. Committed to customer investments despite shareholder impact.

AMCs grow by % each year, up to 5 years. Implementation/licensing revenue significant at project start; AMC accrues over 5 years. New logos and existing AMC renewals at better price.

Retain premium positioning due to strong product. Strict competition affecting price-up efforts. Maintaining current segment; will raise as situation improves.

Not now. Visibility exists but not measuring numbers yet. Holding for this quarter; on the right path.

Management reaffirmed no formal revenue guidance policy. Order book ₹1,244 Cr expected to drive multi-year revenue; implementation cycles 1–5 years.

Historical aspiration (25–27% from 2023–25) abandoned. Management targeting 'high-margin deals' geographically, no %.

Top 5 customers 28.1% of revenue. Loss of major NBFC to competitor (confirmed in Q&A) signals vulnerability. No naming of other customers; vague disclosure.

Order book ₹1,244 Cr (+19% QoQ) but revenue down 3.3% YoY. AMC contracts span 5 years; implementation cycles customer-dependent. Risk: delayed revenue recognition, cash flow volatility.

EBITDA margin 3.6% (Q1 FY27) vs 15.4% (Q4 FY26); employee costs 75% of revenue. Past 2 years forced 'deeply discounted' pricing; 25–27% margin aspiration abandoned. Risk: unable to recover margin as revenue scales.

Management acknowledged 'strict competition' limiting price-up efforts. Retaining 'premium' positioning but at what cost? 2–3 year history of discounting to win deals.

India 56% of revenue. Expansion to Middle East (12%), South Asia (11%), Europe (5%), US (nascent) ongoing, but India-centric model persists. India segment declined due to one-time capitalization event.